Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein that are antagonists of PGD2 receptors. Also described herein are methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
本文描述了一些
PGD2受体
拮抗剂化合物。还描述了包含这些
PGD2受体
拮抗剂化合物的药物组合物和药物。本文还描述了使用这些
PGD2受体
拮抗剂,单独或与其他化合物结合,治疗呼吸系统、心血管系统和其他依赖或介导于
PGD2的疾病或病症的方法。